Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2022-07-29 AGM Information
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Proceedings of 49th Annual General Meeting of the Company held on 29th July, 2022
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the proceedings of the 49th Annual General Meeting (AGM) of Torrent Pharmaceuticals Limited held on 29th July 2022. It summarizes the business transacted at the AGM, including approval of financial statements, dividend declarations, director re-appointment, auditor re-appointment, and issuance of equity shares. The document does not contain the full AGM materials or presentations but is a formal communication of the AGM proceedings. The document length is 3047 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as AGM Information (AGM-R).
2022-07-29 English
Annual General Meeting
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the proceedings of the 49th Annual General Meeting (AGM) of Torrent Pharmaceuticals Limited held on 29th July 2022. It summarizes the business transacted at the AGM, including approval of financial statements, dividend declarations, director re-appointment, auditor re-appointment, and issuance of equity shares. It also mentions that the declaration of voting results and scrutinizer's report will be disclosed separately. The document is a summary or announcement of the AGM proceedings rather than the full AGM presentation materials or detailed minutes. Given the content and context, this document fits best under the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or summaries of AGM proceedings. The document length is 3047 characters, which is consistent with a brief AGM proceedings announcement rather than a full annual report or detailed financial report. Therefore, the classification is AGM-R with high confidence.
2022-07-29 English
Appointment of Company Secretary and Compliance Officer
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding disclosures under SEBI Listing Regulations. It announces the approval of audited standalone financial results and unaudited consolidated financial results for the quarter ended 30th June 2022, along with the audit report and limited review report. It also includes a press release on financial results and announces the appointment of a new Company Secretary and Compliance Officer. The document is relatively short (2868 characters) and primarily serves as an announcement of financial results and management changes rather than containing the full financial statements or detailed analysis. Therefore, it is not an Interim/Quarterly Report (IR) itself but an announcement under Regulation 30. The appointment of a new Company Secretary is a management change. Given the mixed content but primarily the announcement of financial results and management change, the best fitting category is Regulatory Filings (RNS), which is the fallback for such announcements that do not contain full reports or detailed financial data.
2022-07-29 English
Appointment
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for images and no textual content or substantive information. The true document length is only 180 characters, indicating it is extremely short and contains no report or announcement content. Given the lack of any financial data, regulatory references, or report titles, this document does not fit any specific report category. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without meaningful content.
2022-07-29 English
Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30th June, 2022
Investor Presentation Classification · 95% confidence The document is a presentation to analysts on unaudited consolidated financial results for the quarter ended 30th June 2022. It includes financial data summaries for Q1 FY 2022-23, indicating it is a quarterly financial update. The document is not a full annual report or audit report, but a detailed presentation of quarterly results. The presence of slides and financial summaries aligns with an Investor Presentation rather than just an earnings release or regulatory filing. The document length is 1760 characters, which is short but contains substantive financial data and analysis, consistent with an Investor Presentation rather than a brief announcement or certification. Therefore, the most appropriate classification is Investor Presentation (IP).
2022-07-29 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document contains quarterly revenue data for Q1 FY 2022-23 compared to Q1 FY 2021-22, including percentage growth figures. The content is focused on financial performance for a specific quarter and includes substantive financial data. The document length is short but contains actual financial statements and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2022-07-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.